A
Andres Chiesa-Vottero
Researcher at Cleveland Clinic
Publications - 21
Citations - 565
Andres Chiesa-Vottero is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Ovarian tissue cryopreservation & Fertility preservation. The author has an hindex of 9, co-authored 19 publications receiving 494 citations.
Papers
More filters
Journal ArticleDOI
Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma
Andres Chiesa-Vottero,Anais Malpica,Michael T. Deavers,Russell Broaddus,Gerard J. Nuovo,Elvio G. Silva +5 more
TL;DR: It is concluded that p16, owing to its diffuse expression in USC, should not be interpreted as indicating cervical origin or HPV-induced carcinogenesis; however, p16 may be a better marker (albeit unspecific) than p53 for identifying USC.
Journal ArticleDOI
Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus.
TL;DR: The theory that simplex VIN is the most likely precursor of conventional keratinizing SCC, the most common type of vulvar invasive carcinoma, is supported.
Journal ArticleDOI
The Role of Proteasome Inhibition With Bortezomib in the Treatment of Antibody-Mediated Rejection After Kidney-Only or Kidney-Combined Organ Transplantation
Stuart M. Flechner,Richard Fatica,Medhat Askar,B. Stephany,Emilio D. Poggio,Anna Koo,Stacey Banning,Andres Chiesa-Vottero,Titte R. Srinivas +8 more
TL;DR: The bortezomib-containing regimen demonstrated activity in AMR but seems to be most effective before the onset of significant renal dysfunction or proteinuria, which should be evaluated in controlled trials using dosing strategies that include longer courses or retreatment schedules.
Journal ArticleDOI
Scleroderma renal crisis
TL;DR: More than 60 years after its initial description, SRC still remains an important cause of morbidity and mortality in scleroderma and the prognosis of SRC has improved substantially.
Journal ArticleDOI
First birth from a deceased donor uterus in the United States: from severe graft rejection to successful cesarean delivery.
Rebecca Flyckt,Tommaso Falcone,Cristiano Quintini,Uma Perni,Bijan Eghtesad,Elliott G. Richards,Ruth M. Farrell,Koji Hashimoto,Charles Miller,Stephanie Ricci,Cecile A. Ferrando,Giuseppe D’Amico,Shana Maikhor,Debra Priebe,Andres Chiesa-Vottero,Amy Heerema-McKenney,Steven D. Mawhorter,Myra K. Feldman,Andreas Tzakis +18 more
TL;DR: This paper highlights the first live birth in North America resulting from a deceased donor uterus transplant, highlighting the capacity of the transplanted uterus to recover from a severe, prolonged rejection and yet produce a viable neonate.